Meadow Creek Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Meadow Creek Investment Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$761K	Hold	2,288	–	–	0.02%	567
2019 Q2	$715K	Hold	2,288	–	–	0.01%	583
2019 Q1	$699K	Sell	2,288 -440	-16%	-$119K	0.01%	565
2018 Q4	$634K	Sell	2,728 -110	-4%	-$29.5K	0.01%	545
2018 Q3	$888K	Buy	2,838 +968	+52%	+$300K	0.02%	493
2018 Q2	$540K	Hold	1,870	–	–	0.01%	618
2018 Q1	$468K	Hold	1,870	–	–	0.01%	673
2017 Q4	$446K	Buy	1,870 +176	+10%	+$42.6K	0.01%	695
2017 Q3	$376K	Buy	1,694 +198	+13%	+$44.6K	0.01%	691
2017 Q2	$339K	Buy	1,496 +616	+70%	+$134K	0.01%	695
2017 Q1	$175K	Buy	880 +132	+18%	+$25.4K	﹤0.01%	772
2016 Q4	$136K	Buy	+748	New	+$128K	﹤0.01%	819

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Meadow Creek Investment Management's BIO Position: Q3 2019 in Review

Meadow Creek Investment Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2019 at 2,288 shares worth $761K. The position accounts for 0.02% of the portfolio, ranked #567.

Meadow Creek Investment Management first reported a position in BIO in Q4 2016 and has held it in 12 quarters since. The position peaked at $888K in Q3 2018. 355 funds tracked by Wall St. Rank hold BIO as of Q3 2019.

Meadow Creek Investment Management held 2,288 shares of Bio-Rad Laboratories Class A worth $761K as of Q3 2019.
Meadow Creek Investment Management left its Bio-Rad Laboratories Class A share count unchanged in Q3 2019.
Bio-Rad Laboratories Class A made up 0.02% of Meadow Creek Investment Management's portfolio in Q3 2019, its #567 holding.
Meadow Creek Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's Bio-Rad Laboratories Class A position peaked at $888K in Q3 2018.
355 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.